Gilead Sciences's total assets for Q3 2023 were $62.37B, an increase of 0.06% from the previous quarter. GILD total liabilities were $40.13B for the fiscal quarter, a -2.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.